Aluda Pharmaceuticals Inc is a biopharmaceutical company based in Menlo Park, CA, specializing in the development of innovative therapies for autoimmune diseases, fibrosis, and cancer signaling.
The company's research focuses on targeting key proteins such as Vimentin and STAT3 to develop novel treatments that activate regulatory T cells, with the aim of modulating the immune response and improving patient outcomes.
Generated from the website